When was Gemini Bio founded?

Gemini Bio was founded in 1985 and raised its 1st funding round 36 years after it was founded.

Where is Gemini Bio located?

Gemini Bio is headquartered in West Sacramento, United States. It is registered at New York, New York.

How many employees does Gemini Bio have?

As of Sep 30, 2026, the latest employee count at Gemini Bio is 87.

Is Gemini Bio a funded company?

Gemini Bio is a funded company, having raised a total of $5.68M across 2 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Nov 17, 2021.

When was the latest funding round of Gemini Bio?

Gemini Bio's latest funding was a $***** Unattributed round on May 10, 2024, with participation from 0 investor.

Where does Gemini Bio rank among its competitors?

Gemini Bio ranks 15th amongst 933 active competitors, of which 47 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Gemini Bio?

Gemini Bio's top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

Gemini Bio - 2026 Company Profile, Team, Funding & Competitors

Gemini Bio is an acquired company based in West Sacramento (United States), founded in 1985. It operates as a Developer of supplement reagents for cell and gene therapy. Gemini Bio has raised $5.68M in funding. The company has 933 active competitors, including 47 funded and 96 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.

Company Details

Developer of supplement reagents for cell and gene therapy. The company manufactures custom media, animal and human sera, buffers, and other supplement reagents to the scientific community across academic research and the biotechnology, cell and gene therapy, and biopharma industries.

Website: www.geminibio.com/
Phone Number: +1 **********
Registered Address: New York, New York

Key Metrics

Founded Year

1985

Location

West Sacramento, United States

Stage

Acquired

Total Funding

$5.68M in 2 rounds

Latest Funding Round

Unattributed, May 10, 2024, $*****

Investors

Broadoak Capital Partners

Ranked

15^th among 933 active competitors

Employee Count

87 as on Sep 30, 2026

Similar Companies

Abcam & 1072 more

Exit Details

Acquired by BelHealth Investment Partners (Sep 14, 2018)

View Gemini Bio's full profile

Gemini Bio is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
GEMINI BIOPRODUCTS HOLDING, INC. CIN: 32072457008 , United States, Active		$5M - $25M (As on Sep 19, 2023)	-	-
GEMINI BIO PRODUCTS LLC CIN: 831655575 , United States, Active	Dec 31, 1999	-	55 (As on Dec 31, 2024)	-

Gemini Bio got acquired by BelHealth Investment Partners on Sep 14, 2018.

Click here to take a look at Gemini Bio's acquisition in detail

Gemini Bio has raised a total funding of $5.68M over 2 rounds. Its first funding round was on Nov 17, 2021. Gemini Bio has 1 institutional investor.

Here is the list of recent funding rounds of Gemini Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 10, 2024	7878486	Unattributed	8182864	5298986	6887318	2213399
Nov 17, 2021	7769728	Conventional Debt	1383843	4558351	6085247	Broadoak Capital Partners

Access funding benchmarks and valuations. Sign up today!

View details of Gemini Bio's funding rounds and investors

Gemini Bio's employee count trend

Gemini Bio has 87 employees as of Sep 26. Here is Gemini Bio's employee count trend over the years:

Uncover Gemini Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Gemini Bio include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of Gemini Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	Battery Ventures	65/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
5th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
6th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
7th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
8th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	55/100
9th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100
15th	Gemini Bio 1985, West Sacramento (United States), Acquired	Developer of supplement reagents for cell and gene therapy	$5.68M	Broadoak Capital Partners	49/100